HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum antibodies to Porphyromonas gingivalis chaperone HtpG predict health in periodontitis susceptible patients.

AbstractBACKGROUND:
Chaperones are ubiquitous conserved proteins critical in stabilization of new proteins, repair/removal of defective proteins and immunodominant antigens in innate and adaptive immunity. Periodontal disease is a chronic inflammatory infection associated with infection by Porphyromonas gingivalis that culminates in the destruction of the supporting structures of the teeth. We previously reported studies of serum antibodies reactive with the human chaperone Hsp90 in gingivitis, a reversible form of gingival disease confined to the oral soft tissues. In those studies, antibodies were at their highest levels in subjects with the best oral health. We hypothesized that antibodies to the HSP90 homologue of P. gingivalis (HtpG) might be associated with protection/resistance against destructive periodontitis.
METHODOLOGY/PRINCIPAL FINDINGS:
ELISA assays using cloned HtpG and peptide antigens confirmed gingivitis subjects colonized with P. gingivalis had higher serum levels of anti-HtpG and, concomitantly, lower levels of attachment loss. Additionally, serum antibody levels to P. gingivalis HtpG protein were higher in healthy subjects compared to patients with either chronic or aggressive periodontitis. We found a negative association between tooth attachment loss and anti-P. gingivalis HtpG (p = 0.043) but not anti-Fusobacterium nucleatum (an oral opportunistic commensal) HtpG levels. Furthermore, response to periodontal therapy was more successful in subjects having higher levels of anti-P. gingivalis HtpG before treatment (p = 0.018). There was no similar relationship to anti-F. nucleatum HtpG levels. Similar results were obtained when these experiments were repeated with a synthetic peptide of a region of P. gingivalis HtpG.
CONCLUSIONS/SIGNIFICANCE:
OUR RESULTS SUGGEST: 1) anti-P. gingivalis HtpG antibodies are protective and therefore predict health periodontitis-susceptable patients; 2) may augment the host defence to periodontitis and 3) a unique peptide of P. gingivalis HtpG offers significant potential as an effective diagnostic target and vaccine candidate. These results are compatible with a novel immune control mechanism unrelated to direct binding of bacteria.
AuthorsCharles E Shelburne, P Sandra Shelburne, Vishnu M Dhople, Domenica G Sweier, William V Giannobile, Janet S Kinney, Wilson A Coulter, Brian H Mullally, Dennis E Lopatin
JournalPloS one (PLoS One) Vol. 3 Issue 4 Pg. e1984 (Apr 23 2008) ISSN: 1932-6203 [Electronic] United States
PMID18431474 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Bacterial Proteins
  • HSP90 Heat-Shock Proteins
  • Immunoglobulin G
  • Molecular Chaperones
  • Peptides
  • HtpG protein, bacteria
Topics
  • Adult
  • Amino Acid Sequence
  • Antibodies, Bacterial (immunology)
  • Antibody Formation (immunology)
  • Antigens, Bacterial (chemistry, immunology)
  • Bacterial Proteins (chemistry, immunology)
  • Cluster Analysis
  • Colony Count, Microbial
  • Dental Plaque (microbiology)
  • Disease Susceptibility
  • Female
  • Fusobacterium nucleatum (growth & development, immunology)
  • HSP90 Heat-Shock Proteins (chemistry, immunology)
  • Health
  • Humans
  • Immunoglobulin G (immunology)
  • Male
  • Molecular Chaperones (immunology)
  • Molecular Sequence Data
  • Peptides (immunology)
  • Periodontitis (immunology, microbiology)
  • Porphyromonas gingivalis (growth & development, immunology)
  • Serum

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: